查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1268829

2023-2030 年按產品、方法、應用、最終用途、地區、細分市場預測的抗菌藥物敏感性測試市場規模、份額和趨勢分析報告

Antimicrobial Susceptibility Testing Market Size, Share & Trends Analysis Report By Product, By Technique, By Application, By End-use, By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 160 Pages | 商品交期: 2-10個工作天內

價格

抗菌藥物敏感性測試市場增長和趨勢：

Grand View Research, Inc. 的一份新報告顯示，全球抗菌藥敏試驗市場規模從 2023 年到 2030 年將以 5.1% 的複合年增長率增長，到 2030 年將達到 50 億。預計達到8000萬美元。

這一增長主要歸功於技術進步帶來的更多機會、主要參與者研發活動的增加以及抗菌藥敏試驗 (AST) 在有效治療的診斷和鑑定中的滲透率提高。 此外，在藥物發現和開發、臨床實驗室藥敏試驗和個性化醫療等各種應用中越來越多地採用抗菌藥敏試驗也是增長的主要驅動力。

此外，由於缺乏適當的衛生習慣和不衛生的飲食，肺炎和血液感染等傳染病的增加將進一步推動預測期內的增長。 此外，政府機構為抗擊 AMR 而採取的有利舉措預計將在預測期內增加對抗菌藥物敏感性測試的需求。 例如，2020 年 10 月，美國政府宣布了一項“抗擊抗生素耐藥性細菌的國家計劃”，以通過優化抗生素在治療這些疾病中的使用來優先預防感染和改善衛生服務。行動計劃 (CARB) 2020- 2025”正在更新中。

此外，主要參與者越來越關注併購和新產品發布等各種戰略舉措，預計將在預測期內進一步推動市場增長。 例如，2022 年 5 月，Qualigen Therapeutics 達成協議收購 NanoSynex 的多數股權。 NanoSynex 開發了一個 AST 平台來幫助快速識別用於患者感染的抗生素。 預計這些努力將推動未來幾年的增長。

總體而言，由於供應鏈中斷和世界各地政府機構的監管，COVID-19 大流行對 AST 行業產生了負面影響。 然而，COVID-19 給市場帶來了新的機遇。 許多研究表明，抗菌藥物敏感性測試可以幫助在更短的時間內找到治療 COVID-19 疾病的最佳抗生素。 根據美國國家醫學圖書館的說法，直接快速抗生素敏感性測試 (dRAST) 有助於對 COVID-19 患者的菌血症進行早期和最佳的抗生素治療。

然而，技術先進的產品和自動化設備的成本高，確定臨床斷點和批准新抗生素所需的時間長，以及這些產品的複雜批准過程。這些因素可能會阻礙預測期內的市場增長。

抗菌藥敏試驗市場報告要點：

  • 全球抗菌藥敏試驗行業預計將在 2022 年達到 34 億美元，在預測期內以 5.1% 的複合年增長率增長。
  • 2022年人工檢測領域佔比最大，達53.27%。 與自動化測試相比，市場增長是由於可用性和低成本。 然而，自動化測試預計將在預測期內實現最快的 CAGR 驅動增長。
  • 基於技術，光盤擴散部分在 2022 年主導了市場。 這種增長可歸因於各種優勢，例如靈活性和成本效益。 然而，汽車 AST 預計在預測期內以最快的複合年增長率增長。
  • 由於 AMR 和 HAI 病例的增加以及越來越多地採用 AST 進行個性化醫療，醫院部分在 2022 年主導了 AST 行業。
  • 由於人們對藥物發現的興趣日益濃厚，預計生物技術和製藥公司在預測期內將實現最快的增長。
  • 北美在 2022 年將主導全球市場。 行業增長的主要驅動力是技術先進產品的現成可用性和個性化醫療的日益普及。

內容

第一章調查方法及範圍

  • 市場細分和範圍
    • 細分範圍
    • 區域範圍
    • 估計/預測時間表
  • 調查方法
  • 信息採購
    • 購買的數據庫：
    • GVR 內部數據庫
    • 次要信息
    • 初步調查
    • 初步調查的詳細信息
  • 信息或數據分析
    • 數據分析模型
  • 市場形成和驗證
  • 模型詳細信息
    • 產品流分析
      • 方法：商品流方法
  • 調查假設
  • 次要信息列表
  • 縮寫列表
  • 目的

第 2 章執行摘要

  • 市場前景
  • 細分市場展望
  • 競爭考慮

第 3 章抗菌藥物敏感性測試市場變量、趨勢和範圍

  • 市場體系展望
    • 母公司市場
  • 市場動態
    • 市場驅動因素分析
    • 市場製約因素分析
  • 採用和增長前景映射
  • 抗菌藥物敏感性測試：一種市場分析工具
    • 行業分析 - 搬運工
    • PESTLE 分析
  • 監管框架

第 4 章抗菌藥物敏感性測試市場細分分析，按產品分類，2018-2030

  • 定義和範圍
  • 2022 年和 2030 年產品市場份額分析
  • 部門儀表板
  • 2018-2030 年按產品分類的全球抗菌藥物敏感性測試市場
  • 2018-2030年市場規模、預測及趨勢分析
    • 人工檢查
      • 麥克風條
      • 藥敏試驗盤
      • 磁化率板
    • 自動化設備
    • 耗材和介質

第 5 章抗菌藥物敏感性測試市場細分分析，按技術，2018-2030

  • 定義和範圍
  • 2022 年和 2030 年技術市場份額分析
  • 技術部門儀表板
  • 2018-2030 年按技術劃分的全球抗菌藥物敏感性測試市場
  • 2018-2030年市場規模、預測及趨勢分析
    • 自動化 AST
    • 測試方法
    • 稀釋
    • 光盤擴散
    • 其他

第 6 章抗菌藥物敏感性測試市場細分分析，按應用，2018-2030

  • 定義和範圍
  • 2022 年和 2030 年應用市場份額分析
  • 部門儀表板
  • 全球抗菌藥敏試驗市場，按應用，2018-2030 年
  • 2018-2030年市場規模、預測及趨勢分析
    • 藥物開發
    • 敏感性測試
    • 其他

第 7 章按最終用途劃分的抗菌藥物敏感性測試市場細分分析，2018-2030

  • 定義和範圍
  • 2022 年和 2030 年應用市場份額分析
  • 部門儀表板
  • 按最終用途劃分的全球抗菌藥物敏感性測試市場，2018-2030 年
  • 2018-2030年市場規模、預測及趨勢分析
    • 製藥和生物技術公司
    • 診斷實驗室
    • 醫院
    • 其他

第 8 章抗菌藥物敏感性測試市場細分分析，按地區，2018-2030

  • 定義和範圍
  • 2022 年和 2030 年區域市場份額分析
  • 區域市場儀表板
  • 區域市場概況
  • SWOT 分析
    • 北美
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲
  • 2022-2030 年市場規模、預測、收入和趨勢分析
    • 北美
      • 美國
      • 主要國家/地區的趨勢
      • 競爭場景
      • 監管框架
      • 贖回場景
      • 加拿大
      • 主要國家/地區的趨勢
      • 競爭場景
      • 監管框架
      • 贖回場景
    • 歐洲
      • 英國
      • 主要國家/地區的趨勢
      • 競爭場景
      • 監管框架
      • 贖回場景
      • 德國
      • 主要國家/地區的趨勢
      • 競爭場景
      • 監管框架
      • 贖回場景
      • 西班牙
      • 主要國家/地區的趨勢
      • 競爭場景
      • 監管框架
      • 贖回場景
      • 法國
      • 主要國家/地區的趨勢
      • 競爭場景
      • 監管框架
      • 贖回場景
      • 意大利
      • 主要國家/地區的趨勢
      • 競爭場景
      • 監管框架
      • 贖回場景
      • 丹麥
      • 主要國家/地區的趨勢
      • 競爭場景
      • 監管框架
      • 贖回場景
      • 瑞典
      • 主要國家/地區的趨勢
      • 競爭場景
      • 監管框架
      • 贖回場景
      • 挪威
      • 主要國家/地區的趨勢
      • 競爭場景
      • 監管框架
      • 贖回場景
    • 亞太地區
      • 日本
      • 主要國家/地區的趨勢
      • 競爭場景
      • 監管框架
      • 贖回場景
      • 中國
      • 主要國家/地區的趨勢
      • 競爭場景
      • 監管框架
      • 贖回場景
      • 印度
      • 主要國家/地區的趨勢
      • 競爭場景
      • 監管框架
      • 贖回場景
      • 韓國
      • 主要國家/地區的趨勢
      • 競爭場景
      • 監管框架
      • 贖回場景
      • 澳大利亞
      • 主要國家/地區的趨勢
      • 競爭場景
      • 監管框架
      • 贖回場景
      • 泰國
      • 主要國家/地區的趨勢
      • 競爭場景
      • 監管框架
      • 贖回場景
    • 拉丁美洲
      • 巴西
      • 主要國家/地區的趨勢
      • 競爭場景
      • 監管框架
      • 贖回場景
      • 墨西哥
      • 主要國家/地區的趨勢
      • 競爭場景
      • 監管框架
      • 贖回場景
      • 阿根廷
      • 主要國家/地區的趨勢
      • 競爭場景
      • 監管框架
      • 贖回場景
    • 多邊環境協定
      • 南非
      • 主要國家/地區的趨勢
      • 競爭場景
      • 監管框架
      • 贖回場景
      • 沙特阿拉伯
      • 主要國家/地區的趨勢
      • 競爭場景
      • 監管框架
      • 贖回場景
      • 阿拉伯聯合酋長國
      • 主要國家/地區的趨勢
      • 競爭場景
      • 監管的框架
      • 贖回場景
      • 科威特
      • 主要國家/地區的趨勢
      • 競爭場景
      • 監管框架
      • 贖回場景

第 9 章抗菌藥敏試驗市場——競爭分析

  • 主要市場進入者的近期趨勢和影響分析
    • 安索夫矩陣
    • 熱圖分析
    • 主要交易和戰略聯盟分析
  • 公司分類
    • 創新者
    • 市場領導者
  • 供應商情況
    • 主要分銷商和渠道合作夥伴名單
    • 主要客戶
  • 上市公司
    • 競爭儀表板分析
  • 私人公司
    • 主要初創企業名單
  • 公司簡介
    • Bio-Rad Laboratories Inc.
    • Thermo Fisher Scientific Inc.
    • Danaher Corporation
    • BD
    • BIOMERIEUX
    • Creative Diagnostics
    • Hi-Media Laboratories Pvt. Ltd.
    • PerkinElmer, Inc.
    • ELITechGroup
    • F. Hoffmann-La Roche Ltd
Product Code: GVR-4-68040-055-6

Antimicrobial Susceptibility Testing Market Growth & Trends:

The global antimicrobial susceptibility testing market size is expected to reach USD 5.08 billion by 2030, expanding at 5.1% CAGR from 2023 to 2030, according to a new report by Grand View Research, Inc. The growth is primarily attributed to the growing opportunities owing to advancement in technology, increasing R&D activities by leading participants, and increasing penetration of antimicrobial susceptibility testing (AST) in diagnosis and identification of effective treatment options. In addition, the increasing adoption of antimicrobial susceptibility testing in various applications such as drug discovery & development, susceptibility testing in clinical laboratories, and personalized medicine are the leading factors propelling growth.

The increasing prevalence of infectious diseases such as pneumonia and bloodstream infections due to a lack of proper sanitization and an unhygienic diet is further boosting the growth over the forecast period. Moreover, favorable initiatives undertaken by government bodies to combat AMR is anticipated to boost the demand for antimicrobial susceptibility testing over the forecast period. For instance, in October 2020, the U.S. government updated its National Action Plan for Combating Antibiotic-Resistant Bacteria (CARB) 2020-2025 to improve health services by prioritizing infection prevention and optimizing the use of antibiotics in the treatment of these diseases.

Moreover, the rising focus of key players on various strategic initiatives such as mergers & acquisitions and the launching of new products is further expected to drive the market growth over the forecast period. For instance, in May 2022, Qualigen Therapeutics entered into an agreement to acquire a majority stake in NanoSynex. NanoSynex has developed an AST platform to help faster identification of antibiotics for patient infections. Such initiatives are expected to increase growth in the coming years.

Overall, the COVID-19 pandemic impacted the AST industry adversely due to disruption in the supply chain and restrictions imposed by government bodies across the globe. However, COVID-19 opened new opportunities for the market, as many studies stated that antimicrobial susceptibility testing helps find optimal antibiotics in a shorter span for treating COVID-19 disease. According to the National Library of Medicine, a direct rapid antibiotic susceptibility test (dRAST) helps enable earlier & optimal antibiotic treatments for bacteremia in COVID-19 patients.

However, factors such as the high cost of technologically advanced products & automated instruments, the time gap determining clinical breakpoints, approving novel antimicrobial drugs, and the complex approval process of these products may hamper the market growth over the forecast period.

Antimicrobial Susceptibility Testing Market Report Highlights:

  • The global antimicrobial susceptibility testing industry was valued at USD 3.4 billion in 2022 and is projected to grow at a CAGR of 5.1% over the forecast period
  • Manual testing segment held the largest share of 53.27% in 2022. The market growth is attributed to the ease of availability and lower cost as compared to automated testing. However, automated testing is projected to register the fastest CAGR-driven growth over the forecast period
  • Based on technique, the disk diffusion segment dominated the market in 2022. The growth can be attributed to various advantages such as flexibility and cost-effectiveness. However, automated AST is projected to grow at the fastest CAGR during the forecast period
  • Hospital segment dominated the AST industry in 2022 due to increasing AMR & HAIs cases and the growing adoption of AST for personalized medicine
  • Biotechnology & pharmaceutical companies are projected to showcase the fastest growth rate over the forecast period due to a rising focus on drug discovery
  • North America dominated the global market in 2022. The major factors that attribute the industry growth are the easy availability of technologically advanced products and the rising adoption of personalized medicine

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market Segmentation and Scope
    • 1.1.1 Segment scope
    • 1.1.2 Regional scope
    • 1.1.3 Estimates and forecast timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased database:
    • 1.3.2 GVR's internal database
    • 1.3.3 Secondary sources
    • 1.3.4 Primary research
    • 1.3.5 Details of primary research
  • 1.4 Information or Data Analysis
    • 1.4.1 Data analysis models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis
      • 1.6.1.1 Approach: Commodity Flow Approach
  • 1.7 Research Assumptions
  • 1.8 List of Secondary Sources
  • 1.9 List of Abbreviations
  • 1.10 Objectives
    • 1.10.1 Objective 1
    • 1.10.2 Objective 2
    • 1.10.3 Objective 3
    • 1.10.4 Objective 4

Chapter 2 Executive Summary

  • 2.1 Market Outlook
  • 2.2 Segment Outlook
  • 2.3 Competitive Insights

Chapter 3 Antimicrobial Susceptibility Testing Market Variables, Trends, & Scope

  • 3.1 Market Lineage Outlook
    • 3.1.1 Parent market
  • 3.2 Market Dynamics
    • 3.2.1 Market drivers analysis
    • 3.2.2 Market restraint analysis
  • 3.3 Penetration & Growth Prospect Mapping
  • 3.4 Antimicrobial Susceptibility Testing: Market Analysis Tools
    • 3.4.1 Industry analysis - Porter's
    • 3.4.2 PESTLE analysis
  • 3.5 Regulatory Framework

Chapter 4 Antimicrobial Susceptibility Testing Market Segment Analysis, By Product, 2018 - 2030 (USD Million)

  • 4.1 Definition and Scope
  • 4.2 Product Market Share Analysis, 2022 & 2030
  • 4.3 Segment Dashboard
  • 4.4 Global Antimicrobial Susceptibility Testing Market, by Product, 2018 to 2030
  • 4.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
    • 4.5.1 Manual Tests
      • 4.5.1.1 Manual Tests market estimates and forecast, 2018 - 2030 (USD Million)
      • 4.5.1.2 MIC Strips
      • 4.5.1.2.1 MIC Strips market estimates and forecast, 2018 - 2030 (USD Million)
      • 4.5.1.3 Susceptibility Testing Disks
      • 4.5.1.3.1 Susceptibility Testing Disks market estimates and forecast, 2018 - 2030 (USD Million)
      • 4.5.1.4 Susceptibility Plates
      • 4.5.1.4.1 Susceptibility Plates market estimates and forecast, 2018 - 2030 (USD Million)
    • 4.5.2 Automated Instruments
      • 4.5.2.1 Automated Instruments market estimates and forecast, 2018 - 2030 (USD Million)
    • 4.5.3 Consumables & Media
      • 4.5.3.1 Consumables & Media market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 5 Antimicrobial Susceptibility Testing Market Segment Analysis, By Technique 2018 - 2030 (USD Million)

  • 5.1 Definition and Scope
  • 5.2 Technique Market Share Analysis, 2022 & 2030
  • 5.3 Technique Segment Dashboard
  • 5.4 Global Antimicrobial Susceptibility Testing Market, by Technique, 2018 to 2030
  • 5.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
    • 5.5.1 Automated AST
      • 5.5.1.1 Automated AST market estimates and forecast, 2018 - 2030 (USD Million)
    • 5.5.2 Etest Method
      • 5.5.2.1 Etest Method market estimates and forecast, 2018 - 2030 (USD Million)
    • 5.5.3 Dilution
      • 5.5.3.1 Dilution estimates and forecast, 2018 - 2030 (USD Million)
    • 5.5.4 Disk Diffusion
      • 5.5.4.1 Disk Diffusion market estimates and forecast, 2018 - 2030 (USD Million)
    • 5.5.5 Others
      • 5.5.5.1 Others estimates and forecast, 2018 - 2030 (USD Million)

Chapter 6 Antimicrobial Susceptibility Testing Market Segment Analysis, By Application, 2018 - 2030 (USD Million)

  • 6.1 Definition and Scope
  • 6.2 Application Market Share Analysis, 2022 & 2030
  • 6.3 Segment Dashboard
  • 6.4 Global Antimicrobial Susceptibility Testing Market, by Application, 2018 to 2030
  • 6.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
    • 6.5.1 Drug Development
      • 6.5.1.1 Drug development market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.5.2 Susceptibility Testing
      • 6.5.2.1 Susceptibility testing market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.5.3 Others
      • 6.5.3.1 Others market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 7 Antimicrobial Susceptibility Testing Market Segment Analysis, By End-use, 2018 - 2030 (USD Million)

  • 7.1 Definition and Scope
  • 7.2 Application Market Share Analysis, 2022 & 2030
  • 7.3 Segment Dashboard
  • 7.4 Global Antimicrobial Susceptibility Testing Market, by End-Use, 2018 to 2030
  • 7.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
    • 7.5.1 Pharmaceutical & biotechnology companies
      • 7.5.1.1 Pharmaceutical & biotechnology companies market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.5.2 Diagnostic Laboratories
      • 7.5.2.1 Diagnostic laboratories market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.5.3 Hospitals
      • 7.5.3.1 Hospitals market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.5.4 Others
      • 7.5.4.1 Others market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 8 Antimicrobial Susceptibility Testing Market Segment Analysis, By Region, 2018 - 2030 (USD Million)

  • 8.1 Definition & Scope
  • 8.2 Regional Market Share Analysis, 2022 & 2030
  • 8.3 Regional Market Dashboard
  • 8.4 Regional Market Snapshot
  • 8.5 SWOT Analysis
    • 8.5.1 North America
    • 8.5.2 Europe
    • 8.5.3 Asia Pacific
    • 8.5.4 Latin America
    • 8.5.5 Middle East & Africa
  • 8.6 Market Size, & Forecasts, Revenue and Trend Analysis, 2022 to 2030
    • 8.6.1 North America
      • 8.6.1.1 North America Antimicrobial Susceptibility Testing market estimates and forecast, 2018 - 2030 (USD Million)
      • 8.6.1.2 U.S.
      • 8.6.1.2.1 Key Country Dynamics
      • 8.6.1.2.2 Competitive Scenario
      • 8.6.1.2.3 Regulatory Framework
      • 8.6.1.2.4 Reimbursement Scenario
      • 8.6.1.2.5 U.S. Antimicrobial Susceptibility Testing market estimates and forecast, 2018 - 2030 (USD Million)
      • 8.6.1.3 Canada
      • 8.6.1.3.1 Key Country Dynamics
      • 8.6.1.3.2 Competitive Scenario
      • 8.6.1.3.3 Regulatory Framework
      • 8.6.1.3.4 Reimbursement Scenario
      • 8.6.1.3.5 Canada Antimicrobial Susceptibility Testing market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.6.2 Europe
      • 8.6.2.1 Europe Antimicrobial Susceptibility Testing market estimates and forecast, 2018 - 2030 (USD Million)
      • 8.6.2.2 U.K.
      • 8.6.2.2.1 Key Country Dynamics
      • 8.6.2.2.2 Competitive Scenario
      • 8.6.2.2.3 Regulatory Framework
      • 8.6.2.2.4 Reimbursement Scenario
      • 8.6.2.2.5 U.K. Antimicrobial Susceptibility Testing market estimates and forecast, 2018 - 2030 (USD Million)
      • 8.6.2.3 Germany
      • 8.6.2.3.1 Key Country Dynamics
      • 8.6.2.3.2 Competitive Scenario
      • 8.6.2.3.3 Regulatory Framework
      • 8.6.2.3.4 Reimbursement Scenario
      • 8.6.2.3.5 Germany Antimicrobial Susceptibility Testing market estimates and forecast, 2018 - 2030 (USD Million)
      • 8.6.2.4 Spain
      • 8.6.2.4.1 Key Country Dynamics
      • 8.6.2.4.2 Competitive Scenario
      • 8.6.2.4.3 Regulatory Framework
      • 8.6.2.4.4 Reimbursement Scenario
      • 8.6.2.4.5 Spain Antimicrobial Susceptibility Testing market estimates and forecast, 2018 - 2030 (USD Million)
      • 8.6.2.5 France
      • 8.6.2.5.1 Key Country Dynamics
      • 8.6.2.5.2 Competitive Scenario
      • 8.6.2.5.3 Regulatory Framework
      • 8.6.2.5.4 Reimbursement Scenario
      • 8.6.2.5.5 France Antimicrobial Susceptibility Testing market estimates and forecast, 2018 - 2030 (USD Million)
      • 8.6.2.6 Italy
      • 8.6.2.6.1 Key Country Dynamics
      • 8.6.2.6.2 Competitive Scenario
      • 8.6.2.6.3 Regulatory Framework
      • 8.6.2.6.4 Reimbursement Scenario
      • 8.6.2.6.5 Italy Antimicrobial Susceptibility Testing market estimates and forecast, 2018 - 2030 (USD Million)
      • 8.6.2.7 Denmark
      • 8.6.2.7.1 Key Country Dynamics
      • 8.6.2.7.2 Competitive Scenario
      • 8.6.2.7.3 Regulatory Framework
      • 8.6.2.7.4 Reimbursement Scenario
      • 8.6.2.7.5 Denmark Antimicrobial Susceptibility Testing market estimates and forecast, 2018 - 2030 (USD Million)
      • 8.6.2.8 Sweden
      • 8.6.2.8.1 Key Country Dynamics
      • 8.6.2.8.2 Competitive Scenario
      • 8.6.2.8.3 Regulatory Framework
      • 8.6.2.8.4 Reimbursement Scenario
      • 8.6.2.8.5 Sweden Antimicrobial Susceptibility Testing market estimates and forecast, 2018 - 2030 (USD Million)
      • 8.6.2.9 Norway
      • 8.6.2.9.1 Key Country Dynamics
      • 8.6.2.9.2 Competitive Scenario
      • 8.6.2.9.3 Regulatory Framework
      • 8.6.2.9.4 Reimbursement Scenario
      • 8.6.2.9.5 Norway Antimicrobial Susceptibility Testing market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.6.3 Asia Pacific
      • 8.6.3.1 Asia Pacific Antimicrobial Susceptibility Testing market estimates and forecast, 2018 - 2030 (USD Million)
      • 8.6.3.2 Japan
      • 8.6.3.2.1 Key Country Dynamics
      • 8.6.3.2.2 Competitive Scenario
      • 8.6.3.2.3 Regulatory Framework
      • 8.6.3.2.4 Reimbursement Scenario
      • 8.6.3.2.5 Japan Antimicrobial Susceptibility Testing market estimates and forecast, 2018 - 2030 (USD Million)
      • 8.6.3.3 China
      • 8.6.3.3.1 Key Country Dynamics
      • 8.6.3.3.2 Competitive Scenario
      • 8.6.3.3.3 Regulatory Framework
      • 8.6.3.3.4 Reimbursement Scenario
      • 8.6.3.3.5 China Antimicrobial Susceptibility Testing market estimates and forecast, 2018 - 2030 (USD Million)
      • 8.6.3.4 India
      • 8.6.3.4.1 Key Country Dynamics
      • 8.6.3.4.2 Competitive Scenario
      • 8.6.3.4.3 Regulatory Framework
      • 8.6.3.4.4 Reimbursement Scenario
      • 8.6.3.4.5 India Antimicrobial Susceptibility Testing market estimates and forecast, 2018 - 2030 (USD Million)
      • 8.6.3.5 South Korea
      • 8.6.3.5.1 Key Country Dynamics
      • 8.6.3.5.2 Competitive Scenario
      • 8.6.3.5.3 Regulatory Framework
      • 8.6.3.5.4 Reimbursement Scenario
      • 8.6.3.5.5 South Korea Antimicrobial Susceptibility Testing market estimates and forecast, 2018 - 2030 (USD Million)
      • 8.6.3.6 Australia
      • 8.6.3.6.1 Key Country Dynamics
      • 8.6.3.6.2 Competitive Scenario
      • 8.6.3.6.3 Regulatory Framework
      • 8.6.3.6.4 Reimbursement Scenario
      • 8.6.3.6.5 Australia Antimicrobial Susceptibility Testing market estimates and forecast, 2018 - 2030 (USD Million)
      • 8.6.3.7 Thailand
      • 8.6.3.7.1 Key Country Dynamics
      • 8.6.3.7.2 Competitive Scenario
      • 8.6.3.7.3 Regulatory Framework
      • 8.6.3.7.4 Reimbursement Scenario
      • 8.6.3.7.5 Thailand Antimicrobial Susceptibility Testing market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.6.4 Latin America
      • 8.6.4.1 Latin America Antimicrobial Susceptibility Testing market estimates and forecast, 2018 - 2030 (USD Million)
      • 8.6.4.2 Brazil
      • 8.6.4.2.1 Key Country Dynamics
      • 8.6.4.2.2 Competitive Scenario
      • 8.6.4.2.3 Regulatory Framework
      • 8.6.4.2.4 Reimbursement Scenario
      • 8.6.4.2.5 Brazil Antimicrobial Susceptibility Testing market estimates and forecast, 2018 - 2030 (USD Million)
      • 8.6.4.3 Mexico
      • 8.6.4.3.1 Key Country Dynamics
      • 8.6.4.3.2 Competitive Scenario
      • 8.6.4.3.3 Regulatory Framework
      • 8.6.4.3.4 Reimbursement Scenario
      • 8.6.4.3.5 Mexico Antimicrobial Susceptibility Testing market estimates and forecast, 2018 - 2030 (USD Million)
      • 8.6.4.4 Argentina
      • 8.6.4.4.1 Key Country Dynamics
      • 8.6.4.4.2 Competitive Scenario
      • 8.6.4.4.3 Regulatory Framework
      • 8.6.4.4.4 Reimbursement Scenario
      • 8.6.4.4.5 Argentina Antimicrobial Susceptibility Testing market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.6.5 MEA
      • 8.6.5.1 MEA Antimicrobial Susceptibility Testing market estimates and forecast, 2018 - 2030 (USD Million)
      • 8.6.5.2 South Africa
      • 8.6.5.2.1 Key Country Dynamics
      • 8.6.5.2.2 Competitive Scenario
      • 8.6.5.2.3 Regulatory Framework
      • 8.6.5.2.4 Reimbursement Scenario
      • 8.6.5.2.5 South Africa Antimicrobial Susceptibility Testing market estimates and forecast, 2018 - 2030 (USD Million)
      • 8.6.5.3 Saudi Arabia
      • 8.6.5.3.1 Key Country Dynamics
      • 8.6.5.3.2 Competitive Scenario
      • 8.6.5.3.3 Regulatory Framework
      • 8.6.5.3.4 Reimbursement Scenario
      • 8.6.5.3.5 Saudi Arabia Antimicrobial Susceptibility Testing market estimates and forecast, 2018 - 2030 (USD Million)
      • 8.6.5.4 UAE
      • 8.6.5.4.1 Key Country Dynamics
      • 8.6.5.4.2 Competitive Scenario
      • 8.6.5.4.3 Regulatory Framework
      • 8.6.5.4.4 Reimbursement Scenario
      • 8.6.5.4.5 UAE Antimicrobial Susceptibility Testing market estimates and forecast, 2018 - 2030 (USD Million)
      • 8.6.5.5 Kuwait
      • 8.6.5.5.1 Key Country Dynamics
      • 8.6.5.5.2 Competitive Scenario
      • 8.6.5.5.3 Regulatory Framework
      • 8.6.5.5.4 Reimbursement Scenario
      • 8.6.5.5.5 Kuwait Antimicrobial Susceptibility Testing market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 9 Antimicrobial Susceptibility Testing Market - Competitive Analysis

  • 9.1 Recent Developments & Impact Analysis, by Key Market Participants
    • 9.1.1 Ansoff matrix
    • 9.1.2 Heat map analysis
    • 9.1.3 Major Deals and Strategic Alliances Analysis
      • 9.1.3.1 Joint Ventures
      • 9.1.3.2 Licensing Agreements
      • 9.1.3.3 Product Launches
      • 9.1.3.4 Conferences and Campaigns
  • 9.2 Company Categorization
    • 9.2.1 Innovators
    • 9.2.2 Market Leaders
  • 9.3 Vendor Landscape
    • 9.3.1 List of key distributors and channel partners
    • 9.3.2 Key customers
  • 9.4 Public Companies
    • 9.4.1 Competitive Dashboard Analysis
      • 9.4.1.1 Market Differentiators
  • 9.5 Private Companies
    • 9.5.1 List of key emerging companies
  • 9.6 Company Profiles
    • 9.6.1 Bio-Rad Laboratories Inc.
      • 9.6.1.1 Company overview
      • 9.6.1.2 Financial performance
      • 9.6.1.3 Product benchmarking
      • 9.6.1.4 Strategic Initiatives
    • 9.6.2 Thermo Fisher Scientific Inc.
      • 9.6.2.1 Company overview
      • 9.6.2.2 Financial performance
      • 9.6.2.3 Product benchmarking
      • 9.6.2.4 Strategic Initiatives
    • 9.6.3 Danaher Corporation
      • 9.6.3.1 Company overview
      • 9.6.3.2 Financial performance
      • 9.6.3.3 Product benchmarking
      • 9.6.3.4 Strategic Initiatives
    • 9.6.4 BD
      • 9.6.4.1 Company overview
      • 9.6.4.2 Financial performance
      • 9.6.4.3 Product benchmarking
      • 9.6.4.4 Strategic Initiatives
    • 9.6.5 BIOMERIEUX
      • 9.6.5.1 Company overview
      • 9.6.5.2 Financial performance
      • 9.6.5.3 Product benchmarking
      • 9.6.5.4 Strategic Initiatives
    • 9.6.6 Creative Diagnostics
      • 9.6.6.1 Company overview
      • 9.6.6.2 Financial performance
      • 9.6.6.3 Product benchmarking
      • 9.6.6.4 Strategic Initiatives
    • 9.6.7 Hi-Media Laboratories Pvt. Ltd.
      • 9.6.7.1 Company overview
      • 9.6.7.2 Financial performance
      • 9.6.7.3 Product benchmarking
      • 9.6.7.4 Strategic initiatives
    • 9.6.8 PerkinElmer, Inc.
      • 9.6.8.1 Company overview
      • 9.6.8.2 Financial performance
      • 9.6.8.3 Product benchmarking
      • 9.6.8.4 Strategic initiatives
    • 9.6.9 ELITechGroup
      • 9.6.9.1 Company overview
      • 9.6.9.2 Financial performance
      • 9.6.9.3 Product benchmarking
      • 9.6.9.4 Strategic initiatives
    • 9.6.9 F. Hoffmann-La Roche Ltd
      • 9.6.9.1 Company overview
      • 9.6.9.2 Financial performance
      • 9.6.9.3 Product benchmarking
      • 9.6.9.4 Strategic initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global antimicrobial susceptibility testing market, by product, 2018 - 2030 (USD Million)
  • Table 4 Global antimicrobial susceptibility testing market, by technique, 2018 - 2030 (USD Million)
  • Table 5 Global antimicrobial susceptibility testing market, by application, 2018 - 2030 (USD Million)
  • Table 6 Global antimicrobial susceptibility testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 7 Global antimicrobial susceptibility testing market, by region, 2018 - 2030 (USD Million)
  • Table 8 North America antimicrobial susceptibility testing market, by country, 2018 - 2030 (USD Million)
  • Table 9 North America antimicrobial susceptibility testing market, by product, 2018 - 2030 (USD Million)
  • Table 10 North America antimicrobial susceptibility testing market, by technique, 2018 - 2030 (USD Million)
  • Table 11 North America antimicrobial susceptibility testing market, by application, 2018 - 2030 (USD Million)
  • Table 12 North America antimicrobial susceptibility testing market, by end-use, 2018-20
  • Table 13 U.S. antimicrobial susceptibility testing market, by product, 2018 - 2030 (USD Million)
  • Table 14 U.S. antimicrobial susceptibility testing market, by technique, 2018 - 2030 (USD Million)
  • Table 15 U.S. antimicrobial susceptibility testing market, by application, 2018 - 2030 (USD Million)
  • Table 16 U.S. antimicrobial susceptibility testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 17 Canada antimicrobial susceptibility testing market, by product, 2018 - 2030 (USD Million)
  • Table 18 Canada antimicrobial susceptibility testing market, by technique, 2018 - 2030 (USD Million)
  • Table 19 Canada antimicrobial susceptibility testing market, by application, 2018 - 2030 (USD Million)
  • Table 20 Canada antimicrobial susceptibility testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 21 Europe antimicrobial susceptibility testing market, by country, 2018 - 2030 (USD Million)
  • Table 22 Europe antimicrobial susceptibility testing market, by product, 2018 - 2030 (USD Million)
  • Table 23 Europe antimicrobial susceptibility testing market, by technique, 2018 - 2030 (USD Million)
  • Table 24 Europe antimicrobial susceptibility testing market, by application, 2018 - 2030 (USD Million)
  • Table 25 Europe antimicrobial susceptibility testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 26 U.K. antimicrobial susceptibility testing market, by product, 2018 - 2030 (USD Million)
  • Table 27 U.K. antimicrobial susceptibility testing market, by technique, 2018 - 2030 (USD Million)
  • Table 28 U.K. antimicrobial susceptibility testing market, by application, 2018 - 2030 (USD Million)
  • Table 29 U.K. antimicrobial susceptibility testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 30 Germany antimicrobial susceptibility testing market, by product, 2018 - 2030 (USD Million)
  • Table 31 Germany antimicrobial susceptibility testing market, by technique, 2018 - 2030 (USD Million)
  • Table 32 Germany antimicrobial susceptibility testing market, by application, 2018 - 2030 (USD Million)
  • Table 33 Germany antimicrobial susceptibility testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 34 France antimicrobial susceptibility testing market, by product, 2018 - 2030 (USD Million)
  • Table 35 France antimicrobial susceptibility testing market, by technique, 2018 - 2030 (USD Million)
  • Table 36 France antimicrobial susceptibility testing market, by application, 2018 - 2030 (USD Million)
  • Table 37 France antimicrobial susceptibility testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 38 Italy antimicrobial susceptibility testing market, by product, 2018 - 2030 (USD Million)
  • Table 39 Italy antimicrobial susceptibility testing market, by technique, 2018 - 2030 (USD Million)
  • Table 40 Italy antimicrobial susceptibility testing market, by application, 2018 - 2030 (USD Million)
  • Table 41 Italy antimicrobial susceptibility testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 42 Spain antimicrobial susceptibility testing market, by product, 2018 - 2030 (USD Million)
  • Table 43 Spain antimicrobial susceptibility testing market, by technique, 2018 - 2030 (USD Million)
  • Table 44 Spain antimicrobial susceptibility testing market, by application, 2018 - 2030 (USD Million)
  • Table 45 Spain antimicrobial susceptibility testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 46 Sweden antimicrobial susceptibility testing market, by product, 2018 - 2030 (USD Million)
  • Table 47 Sweden antimicrobial susceptibility testing market, by technique, 2018 - 2030 (USD Million)
  • Table 48 Sweden antimicrobial susceptibility testing market, by application, 2018 - 2030 (USD Million)
  • Table 49 Sweden antimicrobial susceptibility testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 50 Denmark antimicrobial susceptibility testing market, by product type, 2018 - 2030 (USD Million)
  • Table 51 Denmark antimicrobial susceptibility testing market, by technique, 2018 - 2030 (USD Million)
  • Table 52 Denmark antimicrobial susceptibility testing market, by application, 2018 - 2030 (USD Million)
  • Table 53 Denmark antimicrobial susceptibility testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 54 Norway antimicrobial susceptibility testing market, by product type, 2018 - 2030 (USD Million)
  • Table 55 Norway antimicrobial susceptibility testing market, by technique, 2018 - 2030 (USD Million)
  • Table 56 Norway antimicrobial susceptibility testing market, by application, 2018 - 2030 (USD Million)
  • Table 57 Norway antimicrobial susceptibility testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 58 Asia Pacific antimicrobial susceptibility testing market, by country, 2018 - 2030 (USD Million)
  • Table 59 Asia Pacific antimicrobial susceptibility testing market, by product type, 2018 - 2030 (USD Million)
  • Table 60 Asia Pacific antimicrobial susceptibility testing market, by technique, 2018 - 2030 (USD Million)
  • Table 61 Asia Pacific antimicrobial susceptibility testing market, by application, 2018 - 2030 (USD Million)
  • Table 62 Asia Pacific antimicrobial susceptibility testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 63 Japan antimicrobial susceptibility testing market, by product type, 2018 - 2030 (USD Million)
  • Table 64 Japan antimicrobial susceptibility testing market, by technique, 2018 - 2030 (USD Million)
  • Table 65 Japan antimicrobial susceptibility testing market, by application, 2018 - 2030 (USD Million)
  • Table 66 Japan antimicrobial susceptibility testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 67 India antimicrobial susceptibility testing market, by product type, 2018 - 2030 (USD Million)
  • Table 68 India antimicrobial susceptibility testing market, by technique, 2018 - 2030 (USD Million)
  • Table 69 India antimicrobial susceptibility testing market, by application, 2018 - 2030 (USD Million)
  • Table 70 India antimicrobial susceptibility testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 71 China antimicrobial susceptibility testing market, by product type, 2018 - 2030 (USD Million)
  • Table 72 China antimicrobial susceptibility testing market, by technique, 2018 - 2030 (USD Million)
  • Table 73 China antimicrobial susceptibility testing market, by application, 2018 - 2030 (USD Million)
  • Table 74 China antimicrobial susceptibility testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 75 Australia antimicrobial susceptibility testing market, by product type, 2018 - 2030 (USD Million)
  • Table 76 Australia antimicrobial susceptibility testing market, by technique, 2018 - 2030 (USD Million)
  • Table 77 Australia antimicrobial susceptibility testing market, by application, 2018 - 2030 (USD Million)
  • Table 78 Australia antimicrobial susceptibility testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 79 South Korea antimicrobial susceptibility testing market, by product type, 2018 - 2030 (USD Million)
  • Table 80 South Korea antimicrobial susceptibility testing market, by technique, 2018 - 2030 (USD Million)
  • Table 81 South Korea antimicrobial susceptibility testing market, by application, 2018 - 2030 (USD Million)
  • Table 82 South Korea antimicrobial susceptibility testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 83 Thailand antimicrobial susceptibility testing market, by product type, 2018 - 2030 (USD Million)
  • Table 84 Thailand antimicrobial susceptibility testing market, by technique, 2018 - 2030 (USD Million)
  • Table 85 Thailand antimicrobial susceptibility testing market, by application, 2018 - 2030 (USD Million)
  • Table 86 Thailand antimicrobial susceptibility testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 87 Latin America antimicrobial susceptibility testing market, by country, 2018 - 2030 (USD Million)
  • Table 88 Latin America antimicrobial susceptibility testing market, by product, 2018 - 2030 (USD Million)
  • Table 89 Latin America antimicrobial susceptibility testing market, by technique, 2018 - 2030 (USD Million)
  • Table 90 Latin America antimicrobial susceptibility testing market, by application, 2018 - 2030 (USD Million)
  • Table 91 Latin America antimicrobial susceptibility testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 92 Brazil antimicrobial susceptibility testing market, by product types, 2018 - 2030 (USD Million)
  • Table 93 Brazil antimicrobial susceptibility testing market, by technique, 2018 - 2030 (USD Million)
  • Table 94 Brazil antimicrobial susceptibility testing market, by application, 2018 - 2030 (USD Million)
  • Table 95 Brazil antimicrobial susceptibility testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 96 Mexico antimicrobial susceptibility testing market, by product type, 2018 - 2030 (USD Million)
  • Table 97 Mexico antimicrobial susceptibility testing market, by technique, 2018 - 2030 (USD Million)
  • Table 98 Mexico antimicrobial susceptibility testing market, by application, 2018 - 2030 (USD Million)
  • Table 99 Mexico antimicrobial susceptibility testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 100 Argentina antimicrobial susceptibility testing market, by product type, 2018 - 2030 (USD Million)
  • Table 101 Argentina antimicrobial susceptibility testing market, by technique, 2018 - 2030 (USD Million)
  • Table 102 Argentina antimicrobial susceptibility testing market, by application, 2018 - 2030 (USD Million)
  • Table 103 Argentina antimicrobial susceptibility testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 104 Middle East & Africa antimicrobial susceptibility testing market, by country, 2018 - 2030 (USD Million)
  • Table 105 Middle East & Africa antimicrobial susceptibility testing market, by product type, 2018 - 2030 (USD Million)
  • Table 106 Middle East & Africa antimicrobial susceptibility testing market, by technique, 2018 - 2030 (USD Million)
  • Table 107 Middle East & Africa antimicrobial susceptibility testing market, by application, 2018 - 2030 (USD Million)
  • Table 108 Middle East & Africa antimicrobial susceptibility testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 109 South Africa antimicrobial susceptibility testing market, by product type, 2018 - 2030 (USD Million)
  • Table 110 South Africa antimicrobial susceptibility testing market, by technique, 2018 - 2030 (USD Million)
  • Table 111 South Africa antimicrobial susceptibility testing market, by application, 2018 - 2030 (USD Million)
  • Table 112 South Africa antimicrobial susceptibility testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 113 Saudi Arabia antimicrobial susceptibility testing market, by product type, 2018 - 2030 (USD Million)
  • Table 114 Saudi Arabia antimicrobial susceptibility testing market, by technique, 2018 - 2030 (USD Million)
  • Table 115 Saudi Arabia antimicrobial susceptibility testing market, by application, 2018 - 2030 (USD Million)
  • Table 116 Saudi Arabia antimicrobial susceptibility testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 117 UAE antimicrobial susceptibility testing market, by product type, 2018 - 2030 (USD Million)
  • Table 118 UAE antimicrobial susceptibility testing market, by technique, 2018 - 2030 (USD Million)
  • Table 119 UAE antimicrobial susceptibility testing market, by application, 2018 - 2030 (USD Million)
  • Table 120 UAE antimicrobial susceptibility testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 121 Kuwait antimicrobial susceptibility testing market, by product type, 2018 - 2030 (USD Million)
  • Table 122 Kuwait antimicrobial susceptibility testing market, by technique, 2018 - 2030 (USD Million)
  • Table 123 Kuwait antimicrobial susceptibility testing market, by application, 2018 - 2030 (USD Million)
  • Table 124 Kuwait antimicrobial susceptibility testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 125 Participant's overview
  • Table 126 Financial performance
  • Table 127 Key Companies undergoing Expansions.
  • Table 128 Key Companies Undertaking Acquisitions.
  • Table 129 Key Companies Undergoing Collaborations.
  • Table 130 Key Companies Launching New Products/Services
  • Table 131 Key Companies Undergoing Partnerships.
  • Table 132 Key Companies Undergoing Other Strategies

List of Figures

  • Fig. 1 Antimicrobial susceptibility testing market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Market snapshot
  • Fig. 10 Segment snapshot
  • Fig. 11 Competitive landscape snapshot
  • Fig. 12 Antimicrobial susceptibility testing market driver analysis
  • Fig. 13 Antimicrobial susceptibility testing market restraint analysis
  • Fig. 14 Antimicrobial susceptibility testing market: Porter's analysis
  • Fig. 15 Antimicrobial susceptibility testing market: PESTLE analysis
  • Fig. 16 Antimicrobial susceptibility testing market: Product outlook and key takeaways
  • Fig. 17 Antimicrobial susceptibility testing market: Product market share analysis, 2022 - 2030
  • Fig. 18 Global manual tests market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 19 Global automated instruments market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 Global consumables & media market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Antimicrobial susceptibility testing market: Technique outlook and key takeaways
  • Fig. 22 Antimicrobial susceptibility testing market: Technique market share analysis, 2022 - 2030
  • Fig. 23 Global automated AST market, 2018 - 2030 (USD million)
  • Fig. 24 Global Etest method market, 2018 - 2030 (USD million)
  • Fig. 25 Global dilution market, 2018 - 2030 (USD million)
  • Fig. 26 Global disk diffusion market, 2018 - 2030 (USD million)
  • Fig. 27 Global others market, 2018 - 2030 (USD million)
  • Fig. 28 Global incident management market, 2018 - 2030 (USD million)
  • Fig. 29 Antimicrobial susceptibility testing market: application outlook and key takeaways
  • Fig. 30 Antimicrobial susceptibility testing market: application market share analysis, 2022 - 2030
  • Fig. 31 Global drug development market, 2018 - 2030 (USD million)
  • Fig. 32 Global susceptibility testing clinics market, 2018 - 2030 (USD million)
  • Fig. 33 Global others market, 2018 - 2030 (USD million)
  • Fig. 34 Antimicrobial susceptibility testing market: End-use outlook and key takeaways
  • Fig. 35 Antimicrobial susceptibility testing market: End-use market share analysis, 2022 - 2030
  • Fig. 36 Global hospitals market, 2018 - 2030 (USD million)
  • Fig. 37 Global diagnostic laboratories market, 2018 - 2030 (USD million)
  • Fig. 38 Global diagnostic biotechnology & pharmaceutical market, 2018 - 2030 (USD million)
  • Fig. 39 Global others market, 2018 - 2030 (USD million)
  • Fig. 40 Regional marketplace: Key takeaways
  • Fig. 41 North America antimicrobial susceptibility testing market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 42 U.S. antimicrobial susceptibility testing market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 43 U.S.: Country dynamics
  • Fig. 44 Canada antimicrobial susceptibility testing market, 2018 - 2030 (USD million)
  • Fig. 45 Canada: Country dynamics
  • Fig. 46 Europe antimicrobial susceptibility testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 47 U.K. antimicrobial susceptibility testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 48 U.K.: Country dynamics
  • Fig. 49 Germany antimicrobial susceptibility testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 50 Germany: Country dynamics
  • Fig. 51 France antimicrobial susceptibility testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 52 France: Country dynamics
  • Fig. 53 Italy antimicrobial susceptibility testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 54 Italy: Country dynamics
  • Fig. 55 Spain antimicrobial susceptibility testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 56 Spain: Country dynamics
  • Fig. 57 Denmark antimicrobial susceptibility testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 58 Denmark: Country dynamics
  • Fig. 59 Sweden antimicrobial susceptibility testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 60 Sweden: Country dynamics
  • Fig. 61 Norway antimicrobial susceptibility testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 62 Norway: Country dynamics
  • Fig. 63 Asia-Pacific antimicrobial susceptibility testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 64 Japan antimicrobial susceptibility testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 65 Japan: Country dynamics
  • Fig. 66 China antimicrobial susceptibility testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 67 China: Country dynamics
  • Fig. 68 India antimicrobial susceptibility testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 69 India: Country dynamics
  • Fig. 70 Australia antimicrobial susceptibility testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 71 Australia: Country dynamics
  • Fig. 72 Thailand antimicrobial susceptibility testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 73 Thailand: Country dynamics
  • Fig. 74 South Korea antimicrobial susceptibility testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 75 South Korea: Country dynamics
  • Fig. 76 Latin America antimicrobial susceptibility testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 77 Brazil antimicrobial susceptibility testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 78 Brazil: Country dynamics
  • Fig. 79 Mexico antimicrobial susceptibility testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 80 Mexico: Country dynamics
  • Fig. 81 Argentina antimicrobial susceptibility testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 82 Argentina: Country dynamics
  • Fig. 83 MEA antimicrobial susceptibility testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 84 South Africa antimicrobial susceptibility testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 85 South Africa: Country dynamics
  • Fig. 86 Saudi Arabia antimicrobial susceptibility testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 87 Saudi Arabia: Country dynamics
  • Fig. 88 UAE antimicrobial susceptibility testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 89 UAE: Country dynamics
  • Fig. 90 Kuwait antimicrobial susceptibility testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 91 Kuwait: Country dynamics
  • Fig. 92 Key company categorization
  • Fig. 93 Company market share analysis
  • Fig. 94 Company market position analysis
  • Fig. 95 Market participant categorization
  • Fig. 96 Strategy framework